I'm planning to attend the AGM. I'm hopeful, but doubtful, some clear guidance will be given re:
(a) what conclusions yet arrived at re Ph 3 results; especially any significant differences between various trial sites, sub-classes of patients on trial (especially prior treatments, KRAS issues, etc)
(b) Thinking re ongoing Ph 2 trials
(c) Overall thoughts re overall future prospects/value of HyAct platform
(d) Fonda - future prospects & plans
(e) VAST - including status of Astra Zeneca deal
(f) budget cutting plans
(e) overall strategy to restore shareholder value
I hope I'm wrong, but recent communications I've had suggested they were going to take 6-8 weeks to come up with real answers to above questions.
The only very small bit of 'solace' I've had in past week or so is that the Ph 3 result has apparently been a huge unexpected shock to all inside ACL
- Forums
- ASX - By Stock
- TSN
- AGM
AGM
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable